Literature DB >> 26598915

Potential of butein, a tetrahydroxychalcone to obliterate cancer.

Ganesan Padmavathi1, Sivakumar Raju Rathnakaram1, Javadi Monisha1, Devivasha Bordoloi1, Nand Kishor Roy1, Ajaikumar B Kunnumakkara2.   

Abstract

BACKGROUND: Despite the major advances made in the field of cancer biology, it still remains one of the most fatal diseases in the world. It is now well established that natural products are safe and efficacious and have high potential in the prevention and treatment of different diseases including cancer. Butein is one such compound which is now found to have anti-cancer properties against various malignancies.
PURPOSE: To thoroughly review the literature available on the anti-cancer properties of butein against different cancers and its molecular targets.
METHODS: A thorough literature search has been done in PubMed for butein, its biological activities especially cancer and its molecular targets.
RESULTS: Our search retrieved several reports on the various biological activities of butein in which around 43 articles reported that butein shows potential anti-proliferative effect against a wide range of neoplasms and the molecular target varies with cancer types. Most often it targets NF-κB and its downstream pathways. In addition, butein induces the expression of genes which mediate the cell death and apoptosis in cancer cells. It also inhibits tumor angiogenesis, invasion and metastasis in prostate, liver and bladder cancers through the inhibition of MMPs, VEGF etc. Moreover, it inhibits the overexpression of several proteins and enzymes such as STAT3, ERK, CXCR4, COX-2, Akt, EGFR, Ras etc. involved in tumorigenesis.
CONCLUSION: Collectively, all these findings suggest the enormous potential and efficacy of butein as a multitargeted chemotherapeutic, chemopreventive and chemosensitizing agent against a wide range of cancers with minimal or no adverse side effects.
Copyright © 2015 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Butein; Cancer; Multitarget; NF-κB; Phytochemical

Mesh:

Substances:

Year:  2015        PMID: 26598915     DOI: 10.1016/j.phymed.2015.08.015

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  17 in total

Review 1.  Cancer drug development: The missing links.

Authors:  Ajaikumar B Kunnumakkara; Devivasha Bordoloi; Bethsebie Lalduhsaki Sailo; Nand Kishor Roy; Krishan Kumar Thakur; Kishore Banik; Mehdi Shakibaei; Subash C Gupta; Bharat B Aggarwal
Journal:  Exp Biol Med (Maywood)       Date:  2019-04-08

2.  The Protective Roles of Butein on Indomethacin Induced Gastric Ulcer in Mice.

Authors:  Rustem Anil Ugan; Harun Un
Journal:  Eurasian J Med       Date:  2020-10

Review 3.  Antiangiogenic Effect of Flavonoids and Chalcones: An Update.

Authors:  Ladislav Mirossay; Lenka Varinská; Ján Mojžiš
Journal:  Int J Mol Sci       Date:  2017-12-22       Impact factor: 5.923

Review 4.  Therapeutic Emergence of Rhein as a Potential Anticancer Drug: A Review of Its Molecular Targets and Anticancer Properties.

Authors:  Sahu Henamayee; Kishore Banik; Bethsebie Lalduhsaki Sailo; Bano Shabnam; Choudhary Harsha; Satti Srilakshmi; Naidu Vgm; Seung Ho Baek; Kwang Seok Ahn; Ajaikumar B Kunnumakkara
Journal:  Molecules       Date:  2020-05-12       Impact factor: 4.411

Review 5.  The Role of Signal Transducer and Activator of Transcription 3 (STAT3) and Its Targeted Inhibition in Hematological Malignancies.

Authors:  Loukik Arora; Alan Prem Kumar; Frank Arfuso; Wee Joo Chng; Gautam Sethi
Journal:  Cancers (Basel)       Date:  2018-09-13       Impact factor: 6.639

Review 6.  Sorcin a Potential Molecular Target for Cancer Therapy.

Authors:  Bano Shabnam; Ganesan Padmavathi; Kishore Banik; Sosmitha Girisa; Javadi Monisha; Gautam Sethi; Lu Fan; Lingzhi Wang; Xinliang Mao; Ajaikumar B Kunnumakkara
Journal:  Transl Oncol       Date:  2018-09-11       Impact factor: 4.243

Review 7.  An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases.

Authors:  Nand Kishor Roy; Dey Parama; Kishore Banik; Devivasha Bordoloi; Amrita Khwairakpam Devi; Krishan Kumar Thakur; Ganesan Padmavathi; Mehdi Shakibaei; Lu Fan; Gautam Sethi; Ajaikumar B Kunnumakkara
Journal:  Int J Mol Sci       Date:  2019-08-22       Impact factor: 5.923

8.  PERK/eIF-2α/CHOP Pathway Dependent ROS Generation Mediates Butein-induced Non-small-cell Lung Cancer Apoptosis and G2/M Phase Arrest.

Authors:  Shouyin Di; Chongxi Fan; Zhiqiang Ma; Mingyang Li; Kai Guo; Donghui Han; Xiaofei Li; Deguang Mu; Xiaolong Yan
Journal:  Int J Biol Sci       Date:  2019-06-04       Impact factor: 6.580

9.  Praeruptorin B Mitigates the Metastatic Ability of Human Renal Carcinoma Cells through Targeting CTSC and CTSV Expression.

Authors:  Chia-Liang Lin; Tung-Wei Hung; Tsung-Ho Ying; Chi-Jui Lin; Yi-Hsien Hsieh; Chien-Min Chen
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923

Review 10.  Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer.

Authors:  Abhishek Manoj Ranaware; Kishore Banik; Vishwas Deshpande; Ganesan Padmavathi; Nand Kishor Roy; Gautam Sethi; Lu Fan; Alan Prem Kumar; Ajaikumar B Kunnumakkara
Journal:  Int J Mol Sci       Date:  2018-08-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.